Vaxcyte, Inc. — Director's Dealing 2021

Apr 7, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vaxcyte, Inc. (PCVX)
CIK: 0001649094
Period of Report: 2021-04-01

Reporting Person: GUGGENHIME ANDREW (President and CFO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-04-01	Stock Option (right to buy)	$20.93	A	145000	Acquired	2031-03-31	Common Stock (145000)	Direct

Footnotes

F1: 1/48 of shares subject to the option vest on May 1, 2021, and 1/48 of the shares vest monthly thereafter.